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Abstract
Brief expression of pluripotency-associated factors such as Oct4, Klf4, Sox2 and c-Myc (OKSM), 
in combination with differentiation-inducing signals, was reported to trigger transdifferentiation of 
fibroblasts into other cell types. Here we show that OKSM expression in mouse fibroblasts gives 
rise to both induced pluripotent stem cells (iPSCs) and induced neural stem cells (iNSCs) under 
conditions previously shown to induce only iNSCs. Fibroblast-derived iNSC colonies silenced 
retroviral transgenes and reactivated silenced X chromosomes, both hallmarks of pluripotent stem 
cells. Moreover, lineage tracing with an Oct4-CreER labeling system demonstrated that virtually 
all iNSC colonies originated from cells transiently expressing Oct4, whereas ablation of Oct4+ 
cells prevented iNSC formation. Lastly, an alternative transdifferentiation cocktail that lacks Oct4 
and was reportedly unable to support induced pluripotency yielded iPSCs and iNSCs carrying the 
Oct4-CreER-derived lineage label. Together, these data suggest that iNSC generation from 
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fibroblasts using OKSM and other pluripotency-related reprogramming factors requires passage 
through a transient iPSC state.
Transdifferentiation is defined as the experimentally induced direct conversion of one cell 
lineage into another. It is typically achieved by ectopic expression of small sets of cell type–
specific transcription factors and has been used to convert fibroblasts into a variety of cell 
types, including myoblasts, cardiomyocytes, hepatocytes and neural cells1. Recently, a more 
general lineage conversion approach has been developed that uses transient expression of 
iPSC-inducing transcription factors. For example, transient expression of OKSM in 
fibroblasts was reported to give rise to iNSCs, pancreatic progenitors, cardiomyocytes, 
hepatocytes, and endothelial cells when pluripotency-inducing signaling (LIF/Stat3) is 
removed and cells are cultured in the presence of lineage-specifying extracellular cues2–8. 
These studies suggested that transient expression of pluripotency-associated transcription 
factors generates a developmentally plastic state that is amenable to transdifferentiation into 
other cell types by exposure of cells to different environmental signals9. Several lines of 
evidence suggested that this process does not involve formation of a transient iPSC state and 
subsequent differentiation. For example, mouse embryonic fibroblasts (MEFs) subjected to 
OKSM transdifferentiation protocols failed to show activation of transgenic pluripotency 
reporters such as Nanog-GFP or Oct4-GFP 2,4,7. Moreover, the kinetics of 
transdifferentiation was shorter than that of induced pluripotency when using certain culture 
conditions, suggesting that iPSCs could not have formed2,4,7. Lastly, an alternative 
transdifferentiation cocktail, Brn4, Klf4, Sox2 and c-Myc (BKSM), also generated iNSCs 
without apparent production of iPSCs3.
The use of OKSM in both induced pluripotency and transdifferentiation protocols raises the 
question of how these transcription factors induce such different cell fates. We therefore 
sought to compare and contrast reprogramming into iPSCs by OKSM and 
transdifferentiation to iNSCs by either OKSM or BKSM.
Reprogrammable MEFs (rep-MEFs), which carry the tetOP-OKSM allele in the Col1a1 
locus, the M2rtTA transgene in the Rosa26 locus and an EGFP reporter in the endogenous 
Oct4 locus (Oct4-GFP)10, exposed to doxycycline (dox) gave rise to iPSCs after 1–2 weeks 
in conventional embryonic stem cell (ESC) medium (serum and LIF)(Fig. 1A, B). In 
contrast, treatment of rep-MEFs with dox in medium containing the NSC cytokines FGF and 
EGF but lacking serum/LIF (NSC medium) yielded clusters of cells that morphologically 
and phenotypically resembled NSC colonies (Fig. 1A, B). For example, cellular projections 
emanating from iNSC-like colonies suggested formation of neurites, which are typically 
seen in brain-derived NSC cultures (Fig. 1B). We picked and expanded individual colonies 
in NSC medium, generating stable clonal cell lines. Immunofluorescence staining and 
microarray gene expression analysis of these cell lines revealed upregulation of key NSC 
markers, such as Sox1, Sox2, Nestin and Glast, at levels similar to those of brain-derived 
NSCs, whereas MEF-related genes, including Col5A1 and Fbln5, were markedly 
downregulated (Fig. 1C, D and Supplementary Fig. 1A). Unsupervised clustering, 
correlation and functional annotation analyses of global mRNA expression data further 
showed that these iNSC-like cells are highly similar to brain-derived NSCs but different 
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from MEFs or iPSCs/ESCs (Supplementary Fig. 1B–D). Cultures expanded from single 
iNSC-like colonies could differentiate into Tuj1+ neurons and GFAP+ astrocytes, 
demonstrating multilineage differentiation potential (Fig. 1E). Together, these results show 
that pulsed OKSM expression with our reprogrammable system in the presence of NSC 
inductive cytokines produces authentic iNSCs (OKSM-iNSCs) that exhibit multipotency, 
self-renewal potential and a high similarity to brain-derived NSCs.
We previously showed that the formation of stable iPSCs requires a minimum of 8–10 days 
of OKSM expression under conventional culture conditions11. To determine the minimal 
time needed to generate iNSCs, we induced rep-MEFs with dox in NSC medium for 
different lengths of time, followed by dox withdrawal before counting iNSC colonies at day 
19. OKSM expression was required for at least 8 days to detect iNSC colonies, as 
determined by staining for Sox1 (Fig. 1F, G). The apparent similarity in temporal factor 
requirement between iNSC and iPSC generation prompted us to ask whether iPSC colonies 
could form in NSC medium, a condition that is incompatible with long-term culture of 
iPSCs. Notably, forced expression of OKSM in rep-MEFs consistently gave rise to rare 
Oct4-GFP+ iPSC-like cells (0.2% of total cell population) in this differentiation-stimulating 
condition (Fig. 1H, I). Unlike brain-derived NSCs or OKSM-iNSCs, these colonies co-
expressed Oct4 and Nanog, ruling out the possibility that they were primitive 
neurectodermal cells that continued to express Oct4 upon exit from pluripotency12 
(Supplementary Figs. 1E, 2A, B). The iPSC-like colonies could be stably propagated in ESC 
medium in the absence of exogenous transgene expression (i.e., after dox withdrawal) and 
showed expression of the pluripotency-associated markers alkaline phosphatase, PECAM1, 
EpCAM and Nanog at levels that were comparable to ESCs, indicating self-renewal capacity 
and faithful molecular reprogramming to pluripotency (Supplementary Fig. 2C–E). Notably, 
the expanded iPSC-like clones contributed to coat-color chimeric mice and to their offspring 
upon injection into blastocyst embryos—a rigorous measure of pluripotency (Fig. 1J). We 
conclude that forced OKSM expression overrides the requirement for serum and LIF/Stat3 
signaling and counteracts differentiation-inducing signals (EGF, FGF), generating authentic, 
germline-competent iPSCs under adverse growth conditions.
These data raise the possibility that certain previously published transdifferentiation 
protocols using OKSM overexpression might have in fact generated transient iPSC cells that 
then differentiated into other cell lineages in response to extracellular cues. To test this 
hypothesis, we first examined the order of events in transdifferentiation by tracking cell 
surface markers by flow cytometry. During reprogramming toward iPSCs, MEFs first 
downregulate the fibroblast-associated marker Thy1 and then upregulate the pluripotency-
associated marker SSEA1 at day 3, followed by EpCAM expression by day 611,13. We 
observed a similar downregulation of Thy1 and an upregulation of EpCAM in a fraction of 
cells (∼5%) at day 6 of OKSM expression under iNSC transdifferentiation conditions, 
although established iNSCs and brain-derived NSCs do not express EpCAM 
(Supplementary Fig. 2F, G). Analysis of SSEA1 expression was not informative because it is 
also expressed by NSCs14. These results show that OKSM-induced lineage conversion 
generates similar phenotypic intermediates as OKSM-induced pluripotency, despite very 
different extracellular stimuli.
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Sorted EpCAM+ intermediates obtained after 6 days of OKSM expression in ESC medium 
give rise to rare dox-independent iPSC colonies, whereas EpCAM− intermediates do not13. 
To prospectively determine whether these subpopulations can give rise to iNSCs, we sorted 
day 6 SSEA1−/EpCAM−, SSEA1+/EpCAM− and SSEA1+/EpCAM+ intermediates 
generated in ESC medium and cultured them in either ESC or NSC medium without dox 
(Fig. 1K, L). Only SSEA1+/EpCAM+ intermediates could produce transgene-independent 
iPSCs or iNSCs (Fig. 1K, L and data not shown). These findings show that iPSCs and iNSCs 
originate from the same rare subpopulation of SSEA1+/EpCAM+ cells that emerge shortly 
after OKSM expression.
Considering that EpCAM+ intermediates typically give rise to Oct4-GFP+ iPSCs under ESC 
culture conditions13 and that rare Oct4-GFP+ cells emerge under NSC transdifferentiation 
conditions (Fig. 1H, I), we next determined the fraction of nascent iNSC colonies that 
expressed the pluripotency gene Oct4 in situ over time using the same Oct4-GFP knock-in 
reporter. The majority of colonies forming at early time-points of OKSM expression (days 
10–12) in NSC medium indeed contained small clusters of Oct4-GFP+ cells, whereas 
colonies at intermediate time points (days 17–22) consisted of Oct4-GFP+ clusters, iNSC-
like clusters or a combination of both (Fig. 1M, N). Oct4-GFP expression was entirely 
silenced upon picking and expansion of these iNSC-like colonies in NSC medium without 
dox (data not shown).
To accurately determine how many colonies expressed Oct4 before becoming iNSCs, we 
used cells carrying a 4-hydroxytamoxifen (4-OHT)-inducible Oct4-CreER allele in 
combination with a Rosa26-loxSTOPlox-EYFP (R26-lsl-EYFP) reporter cassette15 (Fig. 
2A). We first determined the specificity and sensitivity of this lineage tracing system for 
labeling pluripotent cells. To demonstrate that primitive Oct4+ neurectodermal cells12 are 
not labeled with this system in vivo, we treated pregnant females harboring Oct4-CreER; 
R26-lsl-EYFP bitransgenic embryos with tamoxifen at E8.5 and examined resultant fetuses 
at E13.5. We did not detect EYFP expression in the brains of five E13.5 fetuses or in 
derivative NSC cultures (Fig. 2B and Supplementary Fig. 3A, B). However, we noticed 
strong EYFP signal in primordial germ cells in the genital ridge, which are known to express 
Oct4 at E8.5 (Fig. 2B). To ensure that culture of brain-derived NSCs does not spuriously 
activate the Oct4-CreER; R26-lsl-EYFP reporter, we derived NSCs from the brains of E13.5 
fetuses with this genotype and exposed cells to 4-OHT. These NSC lines remained EYFP− 
regardless of whether 4-OHT was added to the culture (Supplementary Fig. 3C). Next, to 
confirm that short-term expression of OKSM does not directly activate the endogenous Oct4 
locus, we transduced Oct4-CreER; R26-lsl-EYFP MEFs with lentiviral vectors co-
expressing tetOP-OKSM and M2-rtTA for 2 or 4 days before measuring EYFP expression 
by flow cytometry. No notable EYFP reporter signal was detected at these early time points 
(Supplementary Fig. 4A). We also failed to detect Oct4-GFP reporter expression after 2 and 
4 days of OKSM expression (Supplementary Fig. 4B). In contrast, long-term induction of 
OKSM in Oct4-CreER; R26-lsl-EYFP MEFs in ESC or NSC media generated EYFP+ iPSCs 
in a 4-OHT-dependent manner (Fig. 2C–E, Supplementary Fig. 5A and data not shown). 
EYFP+ iPSCs derived under NSC conditions expressed Nanog and Oct4, and they 
contributed to midgestation chimeras upon injection into blastocysts, demonstrating 
pluripotency (Fig. 2C–E and Supplementary Fig. 5B, C). Based on these controls, we feel 
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confident that this lineage tracing system and our culture conditions have high specificity 
and sensitivity, allowing us to determine whether nascent iNSCs go through a transient 
Oct4+ state. Similar to EYFP-labeled iPSCs produced in NSC medium (Fig. 2C), all 
recovered Sox1+ iNSC colonies derived from OKSM-expressing Oct4-CreER; R26-lsl-
EYFP MEFs were EYFP+ in the presence of 4-OHT, whereas no EYFP+ iNSC colonies 
were detected in the absence of 4-OHT (Fig. 2F, G). EYFP+ iNSC clusters could be single-
cell subcloned and propagated for over ten passages while maintaining NSC marker 
expression, indicating self-renewal capacity (Fig. 2H, I and Supplementary Fig. 6A–C). 
These results show that all examined iNSCs generated under NSC conditions passed through 
a transient Oct4+ state.
We next applied the Oct4-CreER lineage tracing system to an alternative transdifferentiation 
protocol7 that gave rise to iNSCs but not iPSCs7 after only 4–5 days of Oct4 expression, 
coupled with constitutive expression of Sox2, Klf4 and c-Myc7. We were able to derive 
Sox1+ iNSC lines after only 4–5 days of OKSM expression, followed by 14–21 days of 
OKSM-independent growth, similar to a previous report7 (Fig. 2J and Supplementary Fig. 
7A). All examined Sox1+ iNSC colonies were also EYFP+ (Fig. 2J and Supplementary Fig. 
7A). This alternative transdifferentiation protocol uses a modified NSC medium containing 
KnockOut Serum Replacement (KOSR) and low amounts of serum, which are not included 
in conventional NSC medium7. We surmise that the presence of ascorbic acid in KOSR 
accelerates iPSC formation, as was shown previously16. thus explaining the faster 
appearance of iPSCs and derivative NSCs.
We used the modified transdifferentiation protocol in most subsequent experiments because 
of the higher recovery rate of iNSCs.
To rule out the possibility that our visual quantification of EYFP-marked cells missed single 
iNSCs or small iNSC colonies that underwent direct transdifferentiation, we repeated the 
experiment with MEFs harboring the Oct4-CreER allele in combination with a R26-lsl-DTA 
(Diphtheria Toxin fragment A) allele (Supplementary Fig. 7B). Expression of the DTA gene 
in 4-OHT-induced cells undergoing transdifferentiation or reprogramming is expected to 
ablate nearly all Oct4-expressing cells (Supplementary Fig. 7B–D). Using this system, we 
could not detect any Sox1+ iNSC colonies or Sox1+ single cells in 4-OHT-treated cultures 
compared to untreated cultures (Fig. 2K), confirming that virtually all iNSCs pass through 
an Oct4+ state.
To complement our Oct4 lineage labeling and ablation experiments with independent assays 
of pluripotency, we first examined retroviral silencing in iNSC cultures. Unlike most somatic 
cells, including NSCs, iPSCs efficiently silence retroviral transgenes due to the activity of de 
novo DNA methyltransferases11. We infected rep-MEFs with a retroviral vector 
constitutively expressing tdTomato (Fig. 3A), purified tdTomato+ Rep-MEFs by FACS, and 
exposed them to dox and NSC medium (Fig. 3A, B). Approximately 90% of iNSC colonies 
were tdTomato−, and ∼10% were tdTomato+ (Fig. 3C). We believe that the latter colonies 
represent nascent hybrid iPSC–iNSC colonies that had not yet undergone complete retroviral 
silencing (see also Fig. 1M). Notably, culture of sorted tdTomato+ MEFs in NSC medium 
without dox did not elicit silencing of retroviral transgenes (Supplementary Fig. 8). We 
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previously showed that reprogramming of female fibroblasts to iPSCs reactivates the 
silenced X chromosome, and subsequent differentiation of the iPSCs results in random X 
inactivation17. To determine whether X chromosome reactivation occurs during iNSC 
induction, we sorted GFP− cells from a mixed population of GFP+ and GFP− female tail tip 
fibroblasts (TTFs) carrying an X-linked GFP reporter in a heterozygous configuration (i.e., 
mix of XaGFPXi and XiGFPXa cells). Thus, all sorted GFP− TTFs carried the GFP transgene 
on the inactive X chromosome (XiGFPXa) (Fig. 3D). Infection of these TTFs with 
lentiviruses expressing tetOP-OKSM (STEMCCA)18 and M2rtTA gave rise to iNSC 
colonies after 4–5 days of dox induction, followed by 2–4 weeks of dox-independent growth 
in the modified NSC medium. All Sox1+ iNSC colonies reactivated the silent X 
chromosome as judged by GFP expression in a fraction of cells (Fig. 3E, F). GFP expression 
declined in some clones with continuous passaging of these iNSCs, possibly owing to 
silencing of the transgene or loss of the transgenic X chromosome (Supplementary Fig. 9A). 
However, we did not detect reactivation of GFP in sorted GFP− TTFs after 14 days of 
culture in NSC medium in the absence of OKSM expression, indicating that the silenced X 
chromosome is not spuriously activated by culture in NSC medium (Supplementary Fig. 
9B). Because the percentage of GFP+ cells varied among established iNSC clones, we 
confirmed reactivation of the silenced X chromosome in 7 clonally derived iNSC cultures by 
quantitative RT-PCR for an X-linked marker that distinguishes the maternal (mus musculus) 
and paternal (mus castaneous) X chromosome, respectively (Supplementary Fig. 9C). These 
data reinforce the interpretation that iNSCs transition through a pluripotent intermediate 
state with concomitant X reactivation before undergoing differentiation.
Next, we investigated whether interfering with genes involved in iPSC reprogramming 
affects the generation of iNSCs. Nanog is expressed in pluripotent cells but not in iNSCs 
(Supplementary Fig. 1E), and Nanog deficiency leads to a severe reduction in iPSC 
formation that can be rescued by exposure of cells to ascorbic acid19. Nanog knockout 
MEFs gave rise to 6–8 times more Sox1+ iNSC colonies in the presence of ascorbic acid 
compared to control cultures lacking ascorbate (Fig. 3G, H). Ascorbate acts synergistically 
with the GSK3β inhibitor CHIR-99021 to increase iPSC formation efficiency20. Formation 
of iNSCs from wild-type MEFs was enhanced by exposure to both molecules compared to 
ascorbate alone, further demonstrating that iNSC generation responds to the same signaling 
pathways as iPSC formation (Supplementary Fig. 10A, B).
Finally, we studied a different iNSC transdifferentiation gene cocktail that did not yield 
iPSCs in ESC or NSC medium, namely Brn4, Klf4, Sox2 and c-Myc (BKSM)3. To ensure 
homogeneous expression of all four factors, we engineered a polycistronic lentiviral vector 
encompassing the coding regions for Brn4, Sox2, Klf4 and c-Myc under the control of a 
dox-inducible promoter, akin to the OKSM/STEMCCA system18 (Fig. 4A, B and 
Supplementary Fig. 11A–C). Infection of Sox2-GFP MEFs with lentiviral constructs 
expressing tetOP-BKSM and M2rtTA gave rise to Sox2-GFP+ iNSC-like colonies in the 
presence of dox and neural-inducing cytokines, in agreement with ref. 6 (Supplementary 
Fig. 12A). Of note, formation of iNSC clusters in conventional NSC medium required at 
least 12 days of BKSM expression, rather than 8 days with the OKSM cocktail, and we 
typically obtained ∼10 times fewer colonies (data not shown). BKSM-iNSCs could be 
propagated without dox, demonstrating independence from exogenous factor expression and 
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self-renewal potential (Fig. 4C, Supplementary Fig. 12A and data not shown). Accordingly, 
BKSM-iNSCs activated NSC markers, suggesting faithful molecular reprogramming 
towards an NSC-like state (Fig. 4C, D and Supplementary Fig. 12B, C). Global gene 
expression analysis documented a high degree of similarity between OKSM-iNSCs, BKSM-
iNSCs and brain-derived NSCs regardless of their origin from either fibroblasts or fetal 
brains, , whereas these samples were quite different from the starting MEF population (Fig. 
4F and Supplementary Fig. 12B, C).
In contrast to previous observations3, the BKSM combination generated iPSC-like colonies 
in both ESC and NSC media (Supplementary Fig. 13A and data not shown). As with 
OKSM-iPSCs derived in NSC medium, BKSM-iPSC-like clones activated key endogenous 
pluripotency genes, including Nanog, Oct4 and Zfp42, when replated in ESC medium 
without dox, indicating transgene-independent self-renewal (Fig. 4E and Supplementary Fig. 
13B). The global transcriptional profile of BKSM-iPSC-like cells was highly similar to 
those of ESCs and OKSM-derived iPSCs (Fig. 4F and Supplementary Fig. 13B, C). Lastly, 
BKSM-iPSCs supported the formation of teratomas and the generation of fetal and adult 
chimeras upon blastocyst injection, demonstrating pluripotency (Fig. 4G and Supplementary 
Fig. 13D, E). Like BKSM-iNSCs, BKSM-iPSCs were recovered at a lower frequency and 
with delayed kinetics compared to OKSM-mediated iPSCs (data not shown), further 
supporting the notion of a linked process. Notably, infection of Oct4-CreER; R26-lsl-EYFP 
MEFs with lentiviral constructs expressing M2rtTA and tetOP-BKSM yielded exclusively 
EYFP+ iNSC colonies in the presence of 4-OHT, dox, EGF and FGF (Fig. 4H, I). These 
BKSM-iNSC colonies continued to grow without dox and could be converted into iPSCs 
upon re-addition of dox (Supplementary Fig. 14A–C). Together, these results show that 
transdifferentiation into iNSCs using our polycistronic BKSM cassette inevitably passes 
through a transient Oct4+ state.
A key question is whether our observations extend to other types of lineage conversion using 
either pluripotency or lineage-specific factors. We examined activation of the Oct4-CreER; 
R26-lsl-EYFP reporter during OKSM-induced cardiomyocyte generation2 and Ascl1/Brn2/
Myt1l-driven induced neuron (iN) formation21 from MEFs. OKSM-induced cardiomyocyte 
clusters exhibited rhythmic contractions and expression of cardiac troponin and activated the 
Oct4-CreER; R26-lsl-EYFP reporter in nearly all cases (Fig. 4J, K and Supplementary Fig. 
15A, B). By contrast, transdifferentiation of MEFs into iN-like cells did not activate the 
EYFP reporter, suggesting that passage through an Oct4+ state may be specific to the use of 
pluripotency-related transcription factors (Supplementary Fig. 15C–E).
Here we show that pulsed expression of OKSM or BKSM, two gene cocktails, previously 
used for direct lineage conversion of fibroblasts into iNSCs, causes cells to pass through a 
transient Oct4+ state that silences retroviral transgenes and reactivates silenced X 
chromosomal genes in female somatic cells. We further demonstrate that forced OKSM and 
BKSM expression produces bona fide iPSCs under culture conditions that are incompatible 
with long-term culture of established pluripotent cell lines. These results imply that 
transdifferentiation protocols using pluripotency-associated factors often, if not always, 
involve reprogramming into short-lived iPSCs that rapidly differentiate into various lineages 
as determined by the extracellular environment (Fig. 4L). Our results are consistent with 
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previous findings that retroviral transgenes used to convert fibroblasts into iNSCs by brief 
OKSM expression are predominately silenced3,7, whereas induced neural progenitor cells 
generated by forced expression of lineage-specific factors22 remain transgene-dependent. 
Our data might also explain the recent observation that cells generated through 
transdifferentiation with pluripotency factors exhibit chromosomal aberrations typically 
associated with pluripotent stem cell lines23.
Transient iPSC formation was ruled out in previous transdifferentiation studies owing to (i) 
the lack of Nanog-GFP or Oct4-GFP signal, (ii) the inability to derive iPSCs in culture 
conditions lacking LIF and containing differentiation-associated cytokines, and (iii) the 
different kinetics of direct lineage conversion and iPSC formation. We believe that the 
Nanog-GFP reporter may not be sufficiently sensitive to detect rare reprogramming events in 
heterogeneous bulk cultures. Consistent with this notion, previous studies recorded transient 
Nanog mRNA upregulation between days 6–8 of transdifferentiation by qPCR analysis even 
though no reporter signal was detected2,4. Moreover, transdifferentiation experiments have 
often been performed under optimized culture conditions compared to control iPSC 
experiments, which may inadvertently facilitate fast yet transient iPSC formation. Indeed, 
several transdifferentiation supplements (e.g., CHIR99021, BMP4, bFGF, KOSR/ascorbic 
acid) strongly enhance and accelerate iPSC formation16,20,24. Accordingly, we could reduce 
the minimum number of days of OKSM expression required to derive stable iNSCs from 8 
to 4 days by modifying the culture medium.
Our results show that the absence of LIF and the presence of differentiation-inducing 
cytokines (e.g., FGF, EGF) are not sufficient to block iPSC formation. Thus, forced 
transcription factor expression can effectively compensate for the lack of growth factors 
important for iPSC self-renewal and counteract culture conditions that normally trigger 
ESC/iPSC differentiation. This finding is reminiscent of the observation that forced 
expression of Stat3 or Nanog bypasses the requirement for LIF signaling during ESC 
derivation and iPSC formation25,26. We believe that our single-copy transgenic 
reprogramming system allowed us to increase the efficiency reprogramming through 
homogeneous expression of the four factors, facilitating mechanistic dissection of critical 
intermediate stages. By contrast, iNSC generation in some previous studies was extremely 
inefficient (1–3 iNSC colonies per infection with BKSM; 11 iNSC colonies per 130,000 
infected cells or 0.008% with OKSM) and lengthy (3 weeks with OKSM, 4–6 weeks with 
BKSM expression)3,7 , which was likely due to inefficient retroviral infection of fibroblasts 
or an inadequate expression stoichiometry of all four transgenes. The low efficiency of iNSC 
formation may also explain why iPSCs were not detected upon BKSM overexpression, 
whereas our use of a polycistronic, dox-inducible expression vector gave rise to iPSCs in 
ESC or NSC conditions, albeit at much lower efficiency than OKSM-mediated 
reprogramming.
Pluripotency factor–driven transdifferentiation has been proposed as a safer and more 
efficient alternative to induced pluripotency for therapeutic applications as it does not 
require lengthy iPSC differentiation protocols and avoids potential teratoma formation from 
rare undifferentiated cells. Our study highlights the practical importance of dissecting the 
mechanisms underlying transdifferentiation to determine whether cells transit through a 
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pluripotent state. While transient passage through a pluripotent state is not expected to 
impact in vitro applications of this technology, it will be important to exclude the presence 
of residual iPSCs in potential clinical settings.
Materials and methods
Cell culture
Mouse embryonic fibroblasts (MEFs) were cultured in DMEM supplemented with 1% 
Glutamax, 1% non-essential amino acids (NEAA), 1% Penicillin-Streptomycin, 0.5% β-
mercaptoethanol (all from Life Technologies) and 10% FBS (Gibco). Mouse embryonic 
stem cells (ESCs) and induced pluripotent stem cells (iPSCs) were grown on irradiated 
MEFs (GlobalStem) in KO-DMEM medium (Life Technologies) supplemented with 15% 
FBS, 1% Glutamax, 1% NEAA, 1% Penicillin-Streptomycin, 1% β-mercaptoethanol, and 
1000 Unit/ml LIF (purified in-house). Neural stem cells (NSCs) were cultured in 
DMEM/F12 (Life technologies) supplemented with 1XB27 and 1XN2 cell-supplements 
(Life Technologies), 0.01% Fraction V BSA 7.5% solution (Life Technologies), 1% 
Penicillin-Streptomycin and 10ng/ml bFGF (R&D) and 20ng/ml mouse EGF (Life 
Technologies) (“conventional NSC medium”).
Generation of iNSCs using conventional NSC medium
Conventional NSC medium contained DMEM/F12 (Life Technologies) supplemented with 
1XB27 and 1XN2 cell-supplements (Life Technologies), 0.01% Fraction V BSA 7.5 % 
solution (Life Technologies), 1% Penicillin-Streptomycin and 10ng/ml bFGF (R&D) and 
20ng/ml mouse EGF (Life Technologies); this media formulation was previously used to 
generate iNSCs3. We termed this medium “conventional NSC medium” because it does not 
contain LIF, serum or serum replacement components. For the generation of OKSM-iNSCs, 
reprogrammable MEFs (rep-MEFs) from mice carrying a tetOP-OKSM allele in the Col1a1 
locus and an M2rtTA transgene in the Rosa26 locus10 as well as an EGFP transgene 
knocked into one allele of the Oct4 locus were used for some of the experiments10. 
Alternatively, MEFs or tail tips fibroblasts (TTFs) were reprogrammed into iNSCs by 
infection with lenti-viral vectors expressing M2rtTA in combination with either tetOP-
OKSM or tetOP-BKSM cassettes. In conventional NSC medium, at least 8 days (OKSM) or 
12 days (BKSM) of dox exposure, followed by 7–21 days (OKSM) and 12–24 days 
(BKSM) of dox-independent growth, were usually required to generate iNSCs. For most 
experiments, either 3x104 cells were plated per well of a 6 well plate or 5x105 cells per 
10cm plate in MEF medium a day before dox/NSC medium were administered. Of note, 
low-passage MEFs reprogrammed more efficiently and yielded iNSC colonies faster than 
high-passage MEFs. Individual iNSC colonies were picked onto Poly-L-Ornithine (P4957, 
Sigma) coated plates and propagated in conventional NSC medium. For the generation of 
Nanog knockout (KO) iNSCs, Nanog KO MEFs were infected with lentiviral vectors 
expressing M2rtTA and tetOP-OKSM as previously described19. For each replicate, 3x104 
cells were plated per well a day before dox administration. Cells were reprogrammed in 
conventional NSC medium for 10 days, and then switched to the same NSC medium without 
dox for an additional 7 days before scoring for Sox1+/CAG-GFP+ transgene-independent 
iNSC colonies. For the generation of iNSCs from rep-MEFs using small molecules, a 
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concentration of 50 µg/ml ascorbic acid (Sigma) and 3µM GSK3 inhibitor CHIR-99021 
(Tocris) were used in conventional NSC medium. For each replicate, 3x104 cells were plated 
on 6 well plates the day before dox administration. Serum was added for the first 3 days of 
transdifferentiation to reduce cell death. Small molecules were withdrawn at the same time 
as dox and as previously described20. A concentration of 2 µg/ml doxycycline (dox) (Sigma) 
was used for all transdifferentiation and reprogramming experiments.
Generation of iNSCs using modified NSC medium
Modified NSC medium contained DMEM/F12, 2% FBS, 8% KOSR (Gibco), 1xN2, 1% 
Glutamax, 1% NEAA and 0.5% β-mercaptoethanol (all purchased from Life Technologies) 
and 1000 U/ml LIF (purified in-house). This medium was previously used to generate 
iNSCs7. We termed this NSC medium “modified” because it contains low levels of serum, 
KOSR and LIF. To achieve iNSC induction with this medium, MEFs or TTFs were 
transduced with lentiviral vectors expressing M2rtTA and tetOP-OKSM. For each replicate, 
5x105 cells were plated in a 10cm dish a day before dox administration. OKSM expression 
was induced by adding dox for 4–5 days in modified NSC medium, followed by 2–4 weeks 
of dox-independent growth to select for transgene-independent iNSCs. The generation of 
iNSCs and iPSCs with modified NSC medium required a shorter duration of OKSM 
expression compared to conventional NSC medium (4 vs. 8 days). Moreover, low-passage 
MEFs (passage 3 and below) reprogrammed more efficiently and faster than high-passage 
MEFs. A concentration of 2 µg/ml doxycycline (dox) (Sigma) was used for all 
transdifferentiation and reprogramming experiments.
Generation of iPSCs in NSC medium
Reprogrammable MEFs or MEFs infected with lentiviral vectors expressing M2rtTA and 
tetOP-OKSM were reprogrammed in conventional NSC medium supplemented with dox for 
8–12 days to initiate OKSM expression, before switching to ESC medium without dox. 
Oct4-GFP+ colonies were first observed in NSC medium at around day 10–12; however, 
these cells tended to differentiate into iNSCs after a few days without dox when kept in NSC 
medium. Switching to ESC medium (serum/LIF) prevented this rapid differentiation and 
allowed propagation of dox-independent iPSC colonies.
Generation of Oct4-CreER; Rosa26-loxSTOPlox-EYFP MEFs
Oct4-CreER mice, termed B6(SJL)-Pou5f1tm1.1(Cre/Esr1*)Yseg/J, were purchased from 
Jackson laboratory (Stock number 016829)15. Oct4-CreER mice were crossed with Rosa26-
lox-STOP-lox-EYFP mice27 to produce bitransgenic reporter MEFs and NSCs27. 
Genotyping of the Oct4-CreER allele was performed as previously described15. Cells with 
the correct genotype were infected with lentiviral vectors harboring M2rtTA and tetOP-
OKSM alleles and reprogrammed in either modified or conventional NSC medium. MEFs 
carrying the same genotype were used to derive iPSCs in conventional NSC medium (as 
shown in Fig. 2). 4-hydroxytamoxifen (4-OHT) was used at a concentration of 100nM for all 
experiments and was continuously added to the culture medium during and after dox 
treatment to ensure labeling of Oct4+ cells at all stages of transdifferentiation. For in vivo 
induction, 1mg tamoxifen (Sigma) was diluted in corn oil (10mg/ml) and injected into the 
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peritoneum of a pregnant mouse at embryonic day E8.5 The brains and gonads of recovered 
embryos were dissected and analyzed at E13.5.
Derivation of NSCs from fetuses
Brain-derived NSCs were derived from the heads of E13.5 fetuses as previously described28. 
We used conventional NSC medium for expansion and culture of NSCs.
Scoring for X reactivation during iNSC formation
Tail tip fibroblasts (TTFs) obtained from female mice carrying a CMV-GFP transgene on 
one X chromosome29 were infected with lenti-viral vectors carrying the M2rtTA and tetO-
OKSM constructs without dox. Infected cells were sorted twice on a FACSAriaII machine 
(BD Biosciences) to select for the GFP-negative fraction (sort purity 99.9–100% after 2 
sorting rounds). For each replicate, 3x104 cells were sorted a day before dox administration 
and treated in a 6 well plate. iNSC induction was performed in modified NSC medium in the 
presence of dox for 4–5 days, followed by 2–4 weeks of dox-independent growth before 
scoring for the fraction of GFP+ Sox1+ iNSC colonies.
Retroviral silencing during iNSC induction
Rep-MEFs were infected with retroviral vectors carrying the pMXs-tdTomato construct. 
Cells were then sorted on a FACSAriaII machine (BD Biosciences) to isolate the tdTomato+ 
cell-fraction. For each replicate, 3x104 cells were sorted per well of a 6 well plate and 
cultured in ESC or NSC media supplemented with dox for 12 days. Scoring of iPSC or 
iNSC colonies was performed 7–10 days after dox withdrawal. iNSC induction was 
performed in the presence of serum for the first 3 days of OKSM expression to minimize 
cellular senescence. This modification is in accordance with other reports that used low 
serum during iNSC induction4,7. Fetal brain-derived NSCs were infected with pMXs-
tdTomato retroviral vectors, sorted for the tdTomato+ fraction and cultured for an additional 
4 weeks in conventional NSC medium before measuring the fraction of tdTomato+ NSC 
spheres.
Generation of Oct4-CreER; Rosa26-loxSTOPlox-DTA MEFs
Oct4-CreER mice were crossed with Rosa26-loxSTOPlox-DTA animals30. MEFs were 
isolated from bitransgenic fetuses at E13.5. Generation of iNSCs was performed in modified 
NSC medium. For each replicate, 5x105 cells infected with lenti-viral vectors carrying the 
M2rtTA and tetO-OKSM constructs were plated on a 10cm plate a day before dox treatment. 
Dox was administered for 4–5 days, followed by 2–3 weeks of dox-independent growth. 4-
OHT was added throughout the transdifferentiation protocol at a concentration of 100nM for 
all experiments.
Generation of induced neuronal (iN)-like cells from MEFs
Oct4-CreER; R26-lsl-EYFP MEFs were infected with tetOP-Brn2, tetOP-Ascl1, tetOP-
Myt1l and M2rtTA and reprogrammed as described previously21. Dox was added to the 
medium for 12 days, followed by 7 days of dox-independent growth before measuring Tuj1+ 
iN cells. 4-OHT was used at a concentration of 100nM for all experiments.
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Subcloning of iNSC clones
OKSM-iNSCs (EYFP+) derived from Oct4-CreER; R26-lsl-EYFP MEFs were plated at 50 
cells per 6 well plate using a FACSAriaII sorter (BD Biosciences). Clonal colonies were 
detected 7–10 days after plating. Subclones were picked onto poly-ornithine coated plates 
and propagated until passage 25.
Generation of induced cardiomyocytes
Oct4-CreER; R26-lsl-EYFP MEFs were infected with lentiviral vectors expressing M26rtTA 
and tetOP-OKSM and treated precisely as reported previously to generate induced 
cardiomyocytes2. For each replicate, 5x105 cells were plated on a 10cm plate the day before 
dox exposure to initiate transdifferentiation. Briefly, cells were first cultured in KO-DMEM 
(Life Technologies) supplemented with 15% FBS, 5% KOSR, 1% Glutamax, 1% non-
essential amino acids, 1% penicillin-streptomycin and 1% β-mercaptoethanol. After 6 days 
of growth in this culture condition, cells were switched to medium containing KO-DMEM 
supplemented with 14% KOSR, 1% FBS, 1% Glutamax , 1% non-essential amino acids, 1% 
penicillin-streptomycin, 1% β-mercaptoethanol. During these 9 days, JAK inhibitor (EMD) 
was added to the medium at a concentration of 0.5µM. At day 9, cells were switched to 
“CDM medium”2 containing RPMI-1640 (Life Technologies), 0.5 XN2, 1XB27, 0.05% 
BSA fraction V, 1% Glutamax and 0.5% β-mercaptoethanol. 20ng/ml BMP4 (Stemgent) was 
added for the first 5 days of culture in CDM medium as previously described2. Dox was 
administered for 6–9 days for all experiments. iPSC-like colonies appeared 3–4 days after 
dox withdrawal whereas contracting induced cardiomyocytes were first detected 7–8 days 
after dox withdrawal. Beating colonies could be detected as long as 3–4 weeks after dox 
withdrawal. Scoring of induced cardiomyocytes was performed by counting the fraction of 
EYFP+ colonies that showed rhythmic contractions or by co-immunostaining with 
antibodies against Cardiac Troponin (cTnT) and EYFP 1–2 weeks after dox withdrawal. 4-
OHT was used at a concentration of 100nM for all experiments.
Viral vector production
For retroviral generation, approximately 2x106 T-293 cells were transfected with 4.5 µg 
PCL-ECO (ecotropic envelope) and 4.5 µg pMXs-tdTomato vectors, mixed in transfection 
solution consisting of 300µL Opti-MEM (Gibco) and 27µl of TransIT®-LT1 (Mirus). 
Transfection was performed in regular MEF medium without Penicillin-Streptomycin. 24 
hours post transfection, medium was replaced, and 48 and 72 hours post transfection the 
supernatant was collected, filtered through a 0.45µM filter (Westnet), supplemented with 4–8 
µg/ml Polybrene (Sigma) and added freshly to the cells. For lentiviral generation, ∼6x106 
T-293 cells were transfected in a 10cm culture dish with a solution consisting of 770µL 
Opti-MEM and 50 µl of TransIT®-LT1, Δ8.9 (8.5 µg), VSV-G (5.5 µg) and 11µg of the 
target plasmid (either M2rtTA11, tetOP-OKSM11, tetOP-BKSM, tetOP-Ascl121, tetOP-
Brn221 and tetOP-Myt1l21). Viral supernatant was harvested 48 and 72 hours post 
transfection, filtered and added freshly to the cells. Similar ratios of M2rtTA and tetOP-
OKSM or tetOP-BKSM (1:1) were used for maximal infection efficiency.
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Construction of the BKSM polycistronic expression vector
To achieve co-expression of Brn4, Klf4, Sox2 and cMyc, a novel lentiviral construct 
(“BKSM”) was generated by reengineering the STEMCCA reprogramming vector18. First, a 
DNA fragment consisting of the Oct4 (Pou5f1) gene followed by an F2A peptide and part of 
the Klf4 gene was excised from STEMCCA (OKSM) using NotI and BstZ17I. Next, we 
used AccuPrimeTM Pfx DNA Polymerase (Life Technologies) to generate a fragment 
corresponding to Brn4-F2A-Klf4 by overlapping PCR. To accomplish this, two separate 
reactions were performed using the primer pairs Brn4 5’ NotI/Brn4-F2A 3’ and F2A-Klf4 
5’/Klf4 3’ BstZ17I (see below) under the following cycling conditions: initial denaturation 
at 95°C for 2 minutes followed by 35 cycles of 15 seconds at 95°C and 1 minute at 68°C. 
Aliquots of the two purified amplicons were then mixed in a 1:1 ratio and used in a third 
PCR with primers Brn4 5’ NotI and Klf4 3’ BstZ17I under the following conditions: initial 
denaturation at 95°C for 2 minutes; 5 cycles of 15 seconds at 95°C, 30 seconds at 58°C, and 
2 minutes at 68°C; and 30 cycles of 15 seconds at 95°C, 30 seconds at 63°C, and 2 minutes 
at 68°C. The resulting fragment (Brn4-F2A-Klf4) was gel-purified, digested and inserted by 
directional cloning into the NotI- and BstZ17I-digested STEMCCA lentiviral vector. We 
confirmed the identity of the BKSM polycistronic vector by restriction analysis; DNA 
sequencing and immunostaining (see supplementary data). The primer sequences used were:
Brn4 5’ NotI: ATAAGAATGCGGCCGCCATGGCCACAGCTGCCTCGAATCCCTAC
Brn4-F2A 3’: 
CTTGAGAAGGTCAAAATTCAAAGTCTGTTTCACGCCACTTCCGAG 
ATCGTGGCA GGACGCGTCTGTTTTCACC
F2A-Klf4 5’: 
AAACAGACTTTGAATTTTGACCTTCTCAAGTTGGCGGGAGACGTGGAGTCCA
ACCCAGGGCCCATGGCTAGCGACGCTCTGCTCCC
Klf4 3’ BstZ17I: TCTTTCGTATACTGGGTCCAACTCCGGCCGCAGGAGC
Differentiation potential of iNSCs
To generate neurons, OKSM-iNSCs were grown in NSC medium following removal of the 
growth factors bFGF and EGF for 5–10 days; neuronal cells were identified by 
immunostaining with rabbit anti-Tuj1 antibody (Covance, IgG1, 1:200). Astrocytes were 
generated using NSC medium supplemented with 5% FBS for a duration of 10 days, after 
which they were stained with rabbit anti-GFAP antibody (Dako Z0334, IgG, 1:200). The 
secondary antibody used was donkey anti-rabbit IgG (A10040, Alexa Fluor 546) at a 
concentration of 1:250. See “Immunocytochemistry” section for a detailed protocol.
Immunocytochemistry
Cells were washed twice with 1xPBS, cross-linked in 4% PFA solution for 5–10 minutes, 
washed with 1xPBS and blocked for ½ hour at room temperature (RT) with blocking 
solution (2% BSA dissolved in PBS and 0.1% Triton-X-100). Primary antibody staining was 
performed at RT (1 hour). Appropriate secondary antibodies were added after two washes 
with 1xPBS, followed by incubation for 1 hour at RT. Primary and secondary antibodies 
were diluted in blocking solution. DAPI was used for nuclear counterstaining. The following 
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antibodies were used in this study: rabbit anti-Nanog (AB80892 Abcam, IgG, 1:200), goat 
anti-Oct4 (Santa Cruz sc-8628, IgG 1:200), goat anti-Sox1 (R&D, AF3369, 1:100), goat 
anti-Sox2 (Santa Cruz sc-17320, IgG, 1:200), mouse anti-Nestin (Abcam AB6142, IgG1, 
1:200), goat anti-Glast1/Eaat1 (Santa Cruz SC-7757, IgG, 1:200) , rabbit anti-Brn4/Pou3f4 
(Millipore, IgG, 1:200) chicken anti-GFP/EYFP (AVES, 1:300, GFP-1020) and anti-mouse 
cardiac troponin (cTnT) (DSHB, CT3, 1:1000). Secondary antibodies used were A11056 
Alexa Fluor 546 donkey anti-goat IgG, A21123 Alexa Fluor 546 goat anti-mouse IgG1, 
A10040 Alexa Fluor donkey anti-rabbit IgG and A11055 Alexa Fluor 488 donkey anti-goat 
IgG, all at a 1:250 dilution. 488 goat anti-chicken IgG (A-11039, Life technologies,) or 
Rabbit anti chicken IgY (F4137, Sigma) were used at a dilution of 1:1000. We employed 
anti-EGFP/EYFP antibodies to stain for EYFP when co-immunostaining colonies for Sox1 
or cTnT since the endogenous EYFP protein is quenched by PFA treatment during the 
immunostaining protocol.
Antibody live staining
For live staining of cells, PE-conjugated anti-mouse PeCAM1 (CD31) antibody (12–031182 
eBioscience, 1:200) or PE-conjugated anti-mouse CD326 EpCAM (clone G8.8 12–5791-83, 
eBioscience 1:200) were added directly to the cells. Cells were then incubated at 37C for an 
hour, washed twice with 1xPBS and visualized for surface marker expression.
Flow cytometry analysis of surface markers
Cells were harvested using 0.25% trypsin and resuspended in 1xPBS buffer containing 2% 
FBS (“FACS buffer”). The appropriate conjugated antibodies were added at similar ratios 
(1:200); anti-mouse PE-conjugated CD326 EpCAM (1:200, eBioscience) and anti-mouse 
eFluor 450-conjugated CD90 Thy1.2 (1:200, eBioscience). Cells were incubated on ice for 
20 minutes, washed in 1xPBS, resuspended in FACS buffer, filtered and then analyzed on a 
MACSQuant flow cytometer (Miltenyi Biotec). Analysis was performed using the software 
FlowJo.
RNA extraction and microarrays
RNA (DNase-treated) was extracted using RNAeasy Mini Kit (Qiagen) according to the 
manufacturer’s instructions and subjected to hybridization to the GeneChip Mouse 2.0 ST 
arrays (Affymetrix) at the Partners Center for Personalized Genetic Medicine. Expression 
Console (Affymetrix) was used for RMA. Hierarchical clustering and dendrogram analysis 
were performed using Expander software (EXPression Analyzer and DisplayER). Scatter 
plot, analysis of linear regression coefficients and TTEST analysis were performed using 
Excel. Classification and annotations of upregulated genes were performed using the DAVID 
online functional annotation tool (http://david.abcc.ncifcrf.gov/). RNA was extracted from 
expanded OKSM or BKSM-iNSC clusters that have been propagated for several passages. 
Expression data for MEFs and pluripotent stem cells were previously published20. The 
microarray data has been deposited in NCBI Gene Expression Omnibus (GEO) under 
accession number GSE65951.
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Alkaline phosphatase staining
To detect iPSC colonies, alkaline phosphatase kit (Vector Labs) was used according to the 
manufacturer’s recommendations.
Teratoma formation
Approximately 2x106 BKSM-iPSCs were injected under the flanks of SCID-beige mice. 3–4 
weeks post-injection, mice were sacrificed to harvest tumor masses. Paraffin section and 
hematoxylin and eosin (H&E) staining were performed at the Brigham and Women’s 
Hospital pathology core.
Generation of chimeric mice
Chimeras were generated by blastocyst injections as described previously20. Briefly, 
superovulation was initiated by injecting five female B6D2F1/J mice (Jackson Laboratory) 
with pregnant mare serum (Sigma) by intraperitoneal injection. Two days later, human 
chorionic gonadotropin (Sigma) was administered via intraperitoneal injection, and female 
mice were mated with B6D2F1/J males. After three days, developing blastocysts were 
collected and injected with the indicated cell types. Injected blastocysts were transplanted 
into the uterus of pseudo-pregnant Swiss Webster female mice (Jackson Laboratory; 
approximately 2 months of age) and allowed to develop to midgestation or term. All 
procedures involving animals were performed according to a mouse protocol approved by 
the MGH Subcommittee on Research Animal Care.
Allele-specific real-time PCR for X-linked marker gene
DNase-treated RNA was extracted using the RNAeasy Mini Kit (Qiagen) according to the 
manufacturer’s instructions. Conversion of RNA to cDNA was performed using the 
Transcriptor First Strand cDNA Synthesis Kit (Roche) as per manufacturer’s instructions. 
mRNA levels were measured using Brilliant iii SybrGreen kit (Agilent) on a Stratagene 
Mx3005P qRT-PCR system (Agilent). mRNA levels were normalized to GAPDH. We used 
the following primer sequences for qRT-PCR: Uba1 129/mus musculus-specific primer – 
TGAGCTCCTCAAGACGGCAG. Uba1 mus castaneous-specific primer – 
TGAGCTCCTCAAGACGGCCA. Common Uba1 reverse primer - 
CCTTTTTGCCCAGACCTATF.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Generation of iPSCs and iNSCs under neural culture conditions
(A) Experimental design to generate iPSCs and iNSCs in different culture conditions using 
reprogrammable MEFs (rep-MEFs) harboring the Col1a1-tetOP-OKSM and Rosa26-
M2rtTA alleles and an Oct4-GFP reporter. (B) Representative image of Oct4-GFP+ iPSC 
colony generated in ESC medium (serum + LIF) (upper panel) and Oct4-GFP iNSC-like 
colony generated in NSC medium (−LIF/+FGF, EGF) showing typical spheroid morphology 
with neurite-like structures projecting from the center (bottom panel). Scale bar is 250µM. 
(C) Representative immunoﬂuorescence images showing staining for indicated NSC 
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markers in brain-derived NSCs and OKSM-iNSCs. MEFs served as a negative control. Scale 
bar is 100µM. (D) Expression of NSC or MEF-associated markers in the indicated cell lines 
based on microarray gene expression analysis. (E) Differentiation potential of OKSM-
iNSCs into Tuj1+ neurons and GFAP+ astrocytes. Scale bar is 100µM. (F) Representative 
immunoﬂuorescence image of a Sox1+ iNSC colony obtained after 10 days of OKSM 
expression, followed by 9 days of dox-independent growth. Scale bar is 100µM. Autofluor., 
autofluorescence control. (G) Graph showing the minimal number of days required to 
generate stable Sox1+ iNSC colonies using conventional NSC medium. Doxycycline was 
applied for indicated lengths of time before scoring for iNSC colonies at day 19 to capture 
stable, transgene-independent colonies. For each replicate, 3x104 cells were used (n=3 
independent replicates for each time point; error bars, standard error of the mean (s.e.m.) for 
3 independent experiments). (H) Detection of a rare Oct4-GFP+ iPSC-like colony under 
transdifferentiation conditions in NSC medium. Scale bar is 100µM. (I) Flow cytometric 
analysis for Oct4-GFP expression in bulk rep-MEF cultures subjected to the NSC 
transdifferentiation protocol. The PE-Cy7 channel was used to detect autofluorescence. (J) 
Contribution of NSC medium–derived iPSCs to chimeras as indicated by agouti coat color 
(upper image). Germline offspring (white arrowheads) obtained from a male chimera (red 
arrow) (lower image). (K) Potential of sorted SSEA1+/EpCAM+ and SSEA1+/EpCAM 
intermediates after 6 days of OKSM expression to produce iPSCs in ESC medium or iNSCs 
in conventional NSC medium, respectively. For each replicate, 10x105 cells were plated 
(n=3 independent replicates; error bars, s.e.m for 3 independent experiments, *p<0.05). (L) 
Representative images of an Oct4-GFP+ colony (top image) and a Sox1+ iNSC colony 
(bottom image) obtained from sorted SSEA1+/EpCAM+ intermediates (day 6) in NSC 
medium. White arrowheads indicate an Oct4-GFP colony (top) or clusters of Sox1+ 
expressing cells (bottom). Scale bar is 500µM (Oct4-GFP) or 250µM (Sox1). (M) 
Quantification of Oct4-GFP+ colonies, Oct4-GFP+/iNSC hybrid colonies and Oct4-GFP/
iNSC colonies at the indicated time points after dox withdrawal (w/d). For each replicate, 
3x104 cells were used (n=3 independent replicates for each time point; error bars, s.e.m. for 
3 independent experiments). (N) Representative image of iPSC/iNSC hybrid colonies 
detected during the transdifferentiation protocol. Note the dome-shaped iPSC-like colonies 
in the center and emanating neurites (indicated by black and red arrowheads, respectively). 
Bottom images shows patches of Oct4-GFP reporter expression (white arrowheads) within 
the same colony as shown above. Scale bar is 250µM. Insets show magnification of neurites 
(top) and a representative Oct4-GFP colony (bottom).
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Figure 2. Oct4 lineage tracing and ablation during iNSC induction
(A) Schematic showing lineage tracing approach to test whether iNSCs pass through an 
Oct4+ state. (B) Head and gonads from an Oct4-CreER; R26-lsl-EYFP embryo that was 
induced in utero with 4-OHT (E8.5) and recovered at E13.5. Note that the brain is EYFP 
negative, while the gonads are EYFP positive, indicating specificity of the lineage-tracing 
allele in-vivo. (C) Generation of EYFP+ iPSCs from Oct4-CreER; R26-lsl-EYFP MEFs 
generated in NSC medium. Note that iPSCs are EYFP+ only when 4-OHT is administered to 
the reprogramming medium. Scale bar is 250µM. Autofluor., autofluorescence control. (D) 
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Representative immunoﬂuorescence images for the indicated pluripotency markers in NSC 
medium–derived EYFP+ iPSCs. Scale bar is 100µM. (E) EYFP+ iPSCs, derived in NSC 
medium, contribute to an E13.5 midgestation chimera (upper images); non-chimeric 
littermate lacks EYFP signal (bottom images). (F) Images of EYFP+ OKSM-iNSC colonies 
with typical neurites protruding from the center. OKSM-iNSC colonies remain EYFP when 
4-OHT is not applied. Scale bar is 500µM. (G) Quantification of Sox1+ EYFP+ and Sox1+ 
EYFP iNSC colonies generated in conventional NSC medium after 8–12 days of OKSM 
induction, followed by 14–18 days of dox-independent growth. For each replicate, 3x104 
cells were used (n=3 biological replicates; error bars, s.e.m. for 3 independent experiments, 
*p<0.05). A representative EYFP+ iNSC colony with patches of Sox1+ expressing cells is 
shown to the left. Scale bar is 100µM. (H) Immunofluorescence for EYFP of OKSM-iNSC 
subclone #1 at passage 20, demonstrating continuous and uniform EYFP expression. Scale 
bar is 100µM. (I) Flow cytometric analysis for EYFP expression of the same OKSM-iNSC 
subclone #1. The PE-Cy7 channel was used to control for autofluorescence. (J) 
Quantification of Sox1+ EYFP+ and Sox1+ EYFP iNSC colonies, generated in modified 
NSC medium after 4–5 days of OKSM induction, followed by 2–4 weeks of dox-
independent growth. For each replicate, 5x105 cells were used (n=3 biological replicates; 
error bars, s.e.m. for 3 independent experiments, ***p<0.0005). A representative EYFP+/
Sox1+ iNSC colony is shown to the left. Scale bar is 100µM. (K) Quantification of Sox1+ 
iNSC colonies obtained from Oct4-CreER; R26-lsl-DTA (Diphtheria Toxin fragment A) 
MEFs after 5 days of OKSM expression, followed by 3 weeks of dox-independent growth in 
modified NSC medium in the absence or presence of 4-OHT. For each replicate, 5x105 cells 
were used (n=3 independent replicates; error bars, s.e.m. for 3 independent experiments, 
*p<0.05). Scale bar is 100µM. Autofluor., autofluorescence. Representative images are 
shown to the left.
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Figure 3. Silencing of retroviral transgenes and X chromosome reactivation during iNSCs 
induction
(A) Experimental design to assess retroviral silencing during iNSC formation. (B) 
Representative images comparing tdTomato expression in MEFs, iPSCs, OKSM-iNSCs and 
brain-derived NSCs. Note that tdTomato+ non-reprogrammed MEFs surround the iPSC and 
iNSC colonies. Scale bar is 250µM. (C) Quantification of iNSC colonies expressing 
tdTomato+. For each replicate, 3x104 cells were used (n=5 independent replicates; error bars, 
s.e.m. for 5 independent experiments, *p<0.05). (D) Experimental design to follow X 
chromosome inactivation status during iNSC formation. Tail tip fibroblasts (TTFs) from a 
female mouse heterozygous for an X-linked CMV-GFP reporter (mix of XiGFPXa and 
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XiXaGFP cells) were sorted twice for cells that carried the GFP transgene on the inactive X 
chromosome (XiGFPXa). These cells were reprogramed for 4–5 days in modified NSC 
medium, after which dox was withdrawn and GFP expression was assessed in emerging 
Sox1+ iNSC colonies 2–4 weeks later. (E) Representative immunoﬂuorescence images of 
Sox1+ iNSC colonies that show reactivation of the silent XiGFP reporter. Scale bar is 250µM. 
(F) Quantification of Sox1+ iNSC colonies that reactivated the silenced X chromosome as 
determined by GFP reporter reactivation. All examined Sox1+ iNSC colonies showed patchy 
GFP expression. For each replicate, 3x104 cells were used (n=3 independent replicates; error 
bars, s.e.m. for 3 independent experiments, ***p<0.0005). (G) Representative 
immunoﬂuorescence images showing Nanog knockout Sox1+ iNSC colony generated in the 
presence of ascorbate. Nanog-deficient iNSCs express the constitutive CAG-GFP marker, 
confirming their origin from Nanog-mutant MEFs. Scale bar is 100µM. Autofluor., 
autofluorescence control. (H) Quantification of Sox1+ iNSC colonies generated from 
Nanog-deficient MEFs with and without ascorbate. For each replicate, 3x104 cells were used 
(n=3 independent replicates; error bars, s.e.m. for 3 independent experiments, **p<0.005).
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Figure 4. An alternative transdifferentiation cocktail generates iNSCs and iPSCs via an Oct4+ 
intermediate stage
(A) Replacement of the Oct4 gene within the Oct4-Klf4-Sox2-cMyc (OKSM cassette) by 
the neuronal transcription factor Brn4 (BKSM cassette). (B) Experimental design to 
generate iPSCs and iNSCs using the BKSM cassette from MEFs harboring a Sox2-GFP 
knock-in allele in ESC or NSC culture conditions. (C) Immunoﬂuorescence of typical NSC 
markers in an expanded BKSM-iNSC clone. Scale bar is 100µM. (D) Expression of selected 
NSC-associated genes in indicated cell lines based on microarray data. Microarray analysis 
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was performed on expanded clonal iNSC cultures. (E) Immunoﬂuorescence for indicated 
pluripotency markers in expanded BKSM-iPSC clone. Scale bar is 250µM. (F) Dendrogram 
based on microarray analysis of indicated samples. Note that BKSM-iNSCs and OKSM-
iNSCs cluster with brain-derived NSCs while BKSM-iPSCs cluster with mouse ESCs. (G) 
Contribution of BKSM-iPSCs to an adult chimera as shown by agouti coat color. (H) 
Representative images of EYFP+ BKSM-iNSC colonies with emanating neurites generated 
from MEFs in conventional NSC medium. Scale bar is 500µM for iNSC colony (left) and 
100µM for neurites (right). Autofluor., autofluorescence control. (I) Quantification of 
EYFP+ BKSM-iNSC colonies, demonstrating that all of the examined BKSM-iNSC 
colonies transitioned through an Oct4+ state. For each replicate, 5x105 cells were used (n=3 
biological replicates; error bars, s.e.m. for 3 independent experiments, **p<0.005). (J) 
Representative images showing EYFP+ cells in a cluster of beating cardiomyocytes (red 
arrowheads). (K) Quantification of EYFP+, EYFP and EYFP+/EYFP contracting induced 
cardiomyocyte colonies derived from Oct4-CreER; R26-lsl-EYFP MEFs upon short OKSM 
expression in cardiac transdifferentiation conditions. For each replicate, 5x105 cells were 
used (n=3 biological replicates; error bars, s.e.m. for 3 independent experiments, 
**p<0.005). (L) Summary.
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